ArticleBlood cancer journal2025

Long-term outcomes and treatment patterns in Waldenström macroglobulinemia patients who discontinue Bruton tyrosine kinase inhibitor (BTKi) therapy.

Karan L Chohan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.